Vietnam approves the Abdala COVID-19 vaccine developed by Cuba.
Cuban health regulator CECMED approves the emergency use of the domestically-produced Abdala vaccine, becoming the fifth COVID-19 vaccine to be approved in the country. Manufacturers last month claimed that the vaccine, which requires three doses, has a 92% effectiveness rate against the virus. This makes Cuba the first Caribbean and Latin American country to successfully develop its own variation of the vaccine.
Cuba initiates its mass vaccination campaign for around 1.7 million people, using its locally-developed SOBERANA 02 and ABDALA vaccines, both of which have yet to complete its Phase III clinical trials.